Compounds > etodolac

etodolac and 4-nitroquinoline-1-oxide

etodolac has been researched along with 4-nitroquinoline-1-oxide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denda, A; Kirita, T; Kitayama, W; Kuniyasu, H; Morisaki, A; Yamamoto, K1
Denda, A; Inoue, M; Kirita, T; Kitayama, W; Kuniyasu, H; Morisaki, A; Yamamoto, K1
Denda, A; Kirita, T; Kitayama, W; Kuniyasu, H; Sasahira, T; Yamamoto, K1

Other Studies

3 other study(ies) available for etodolac and 4-nitroquinoline-1-oxide

ArticleYear
Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide.
    Cancer letters, 2003, Sep-25, Volume: 199, Issue:2

    Topics: 4-Nitroquinoline-1-oxide; Animals; Blotting, Western; Carcinogens; Carcinoma, Squamous Cell; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diet; Etodolac; Hyperplasia; Immunoenzyme Techniques; Isoenzymes; Kidney; Liver; Male; Organ Size; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Sulfonamides; Tongue Neoplasms

2003
Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2004, Volume: 56, Issue:3

    Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Etodolac; Immunohistochemistry; Male; Precancerous Conditions; Quinolones; Rats; Rats, Inbred F344; Tongue; Tongue Neoplasms; Water Supply

2004
Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
    Pathobiology : journal of immunopathology, molecular and cellular biology, 2006, Volume: 73, Issue:6

    Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Cell Transformation, Neoplastic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Etodolac; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Male; Quinolones; Rats; Rats, Inbred F344; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tongue; Tongue Neoplasms

2006